{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:24:31Z","timestamp":1790004271709,"version":"4.0.1"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.molimm.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T18:14:28Z","timestamp":1565806468000},"page":"299-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management"],"prefix":"10.1016","volume":"114","author":[{"given":"Jutta","family":"Schr\u00f6der-Braunstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kirschfink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1418\u20131420","key":"10.1016\/j.molimm.2019.08.002_bib0005","first-page":"e1410","article-title":"Leukocyte adhesion deficiency-I: a comprehensive review of all published cases","volume":"6","author":"Almarza Novoa","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.molimm.2019.08.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005409","article-title":"Association of a new FCN3 haplotype with high ficolin-3 levels in leprosy","volume":"11","author":"Andrade","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/168.1.227","article-title":"Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component deficient individuals","volume":"168","author":"Andreoni","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0025","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1681\/ASN.2017010031","article-title":"The phenotypic Spectrum of nephropathies associated with mutations in diacylglycerol kinase epsilon","volume":"28","author":"Azukaitis","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.blre.2017.02.003","article-title":"Complementopathies","volume":"31","author":"Baines","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.molimm.2019.08.002_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","article-title":"Complement and autoimmunity","volume":"56","author":"Ballanti","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.molimm.2019.08.002_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.semnephrol.2013.08.002","article-title":"Dense deposit disease and C3 glomerulopathy","volume":"33","author":"Barbour","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2015.03.245","article-title":"MBL-associated serine proteases (MASPs) and infectious diseases","volume":"67","author":"Beltrame","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/infdis\/162.1.248","article-title":"C4B deficiency: a risk factor for bacteremia with encapsulated organisms","volume":"162","author":"Bishof","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fimmu.2018.00500","article-title":"Functional complement analysis can predict genetic testing results and long-term outcome in patients with complement deficiencies","volume":"9","author":"Blazina","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123572","article-title":"Anti-C1q antibodies as a follow-up marker in SLE patients","volume":"10","author":"Bock","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069054","article-title":"Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5","volume":"8","author":"Boldt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-012-9770-4","article-title":"Susceptibility to leprosy is associated with M-ficolin polymorphisms","volume":"33","author":"Boldt","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2013.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor","volume":"33","author":"Bork","year":"2013","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.molimm.2019.08.002_bib0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2500\/aap.2013.34.3677","article-title":"Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review","volume":"34","author":"Bork","year":"2013","journal-title":"Allergy Asthma Proc."},{"issue":"617-629","key":"10.1016\/j.molimm.2019.08.002_bib0085","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/j.chom.2019.02.016","article-title":"Complement C4 Prevents Viral Infection through Capsid Inactivation","volume":"25","author":"Bottermann","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molimm.2019.08.002_bib0090","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.0954-6820.1986.tb02792.x","article-title":"Plasma concentrations of complement split product C3d and immune complexes after procainamide induced production of antinuclear antibodies","volume":"220","author":"Brandslund","year":"1986","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.molimm.2019.08.002_bib0105","article-title":"Recommendations for serogroup B meningococcal vaccine for persons 10 years and older","volume":"138","author":"Brady","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.molimm.2019.08.002_bib0110","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2019.08.002_bib0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/ped.2014.0425","article-title":"Pathophysiology of hereditary angioedema","volume":"27","author":"Caccia","year":"2014","journal-title":"Pediatr. Allergy Immunol. Pulmonol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0120","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jaip.2017.02.025","article-title":"Undetectable mannose binding lectin and corticosteroids increase serious infection risk in rheumatoid arthritis","volume":"5","author":"Carroll","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.molimm.2019.08.002_bib0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nri1456","article-title":"A protective role for innate immunity in systemic lupus erythematosus","volume":"4","author":"Carroll","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0130","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/infdis\/165.5.942","article-title":"C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria","volume":"165","author":"Cates","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2018.05.018","article-title":"Properdin: a multifaceted molecule involved in inflammation and diseases","volume":"102","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","article-title":"Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0145","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1537-2995.2007.01239.x","article-title":"Recombinant human C1-inhibitor in the treatment of acute angioedema attacks","volume":"47","author":"Choi","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.molimm.2019.08.002_bib0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000633","article-title":"Complement, infection, and autoimmunity","author":"Conigliaro","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.12688\/f1000research.10364.1","article-title":"C3 glomerulopathy","volume":"6","author":"Cook","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.molimm.2019.08.002_bib0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0170","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20040111","article-title":"A population-based study of morbidity and mortality in mannose-binding lectin deficiency","volume":"199","author":"Dahl","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.imbio.2015.05.015","article-title":"Complement genetics and susceptibility to inflammatory disease. Lessons from genotype-phenotype correlations","volume":"221","author":"de Cordoba","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2019.08.002_bib0180","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/thoraxjnl-2016-209931","article-title":"Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD","volume":"73","author":"Dicker","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.molimm.2019.08.002_bib0185","doi-asserted-by":"crossref","first-page":"31877","DOI":"10.1038\/srep31877","article-title":"MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked","volume":"6","author":"Dobo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2019.08.002_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies against complement components and functional consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/590006","article-title":"Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection","volume":"47","author":"Eisen","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0200","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3389\/fimmu.2018.02237","article-title":"Interpretation of serological complement biomarkers in disease","volume":"9","author":"Ekdahl","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.inf.0000256751.76218.7c","article-title":"Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood","volume":"26","author":"Faber","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.molimm.2019.08.002_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2019.00254","article-title":"Beta2-integrins and interacting proteins in leukocyte trafficking, immune suppression, and immunodeficiency disease","volume":"10","author":"Fagerholm","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0215","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.molimm.2019.08.002_bib0220","first-page":"400","article-title":"The genetics of atypical hemolytic uremic syndrome","volume":"30","author":"Feitz","year":"2018","journal-title":"Med. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.08.002_bib0230","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1998.00738.x","article-title":"Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine","volume":"114","author":"Fijen","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(89)90712-5","article-title":"Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups","volume":"2","author":"Fijen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2019.08.002_bib0240","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.imbio.2006.11.005","article-title":"The clearance of apoptotic cells by complement","volume":"212","author":"Flierman","year":"2007","journal-title":"Immunobiology"},{"issue":"Suppl 2","key":"10.1016\/j.molimm.2019.08.002_bib0245","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(16)30365-6","article-title":"Examining coagulation-complement crosstalk: complement activation and thrombosis","volume":"141","author":"Foley","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.molimm.2019.08.002_bib0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2249.2007.03479.x","article-title":"Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis","volume":"150","author":"Frakking","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0255","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0260","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2019.08.002_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfs441","article-title":"C3 glomerulonephritis and CFHR5 nephropathy","volume":"28","author":"Gale","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2019.08.002_bib0270","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.18632\/oncotarget.22963","article-title":"A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma","volume":"9","author":"Gallenkamp","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.molimm.2019.08.002_bib0275","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jaci.2006.08.004","article-title":"Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency","volume":"118","author":"Garcia-Laorden","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"368\u2013374","key":"10.1016\/j.molimm.2019.08.002_bib0280","first-page":"e361","article-title":"Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults","volume":"122","author":"Garcia-Laorden","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","article-title":"The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment","volume":"84","author":"Geerlings","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0290","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molimm.2019.08.002_bib0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0305","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06389.x","article-title":"Leukocyte adhesion deficiencies","volume":"1250","author":"Hanna","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2019.08.002_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178032","article-title":"The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants","volume":"12","author":"Hartz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2011.11.002","article-title":"Mannan-binding lectin deficiency - Good news, bad news, doesn\u2019t matter?","volume":"143","author":"Heitzeneder","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0325","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00103-015-2253-z","article-title":"Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease","volume":"58","author":"Hellenbrand","year":"2015","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.molimm.2019.08.002_bib0330","first-page":"1049","article-title":"Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease","volume":"353","author":"Hibberd","year":"1999","journal-title":"Meningococcal Research Group. Lancet"},{"key":"10.1016\/j.molimm.2019.08.002_bib0335","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1172\/JCI114384","article-title":"Complete and partial deficiencies of complement factor D in a Dutch family","volume":"84","author":"Hiemstra","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.08.002_bib0340","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molimm.2019.08.002_bib0345","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1308104","article-title":"Targeted therapy with eculizumab for inherited CD59 deficiency","volume":"370","author":"Hochsmann","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0350","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jclinpath-2015-203065","article-title":"Mannose-binding lectin deficiency and predisposition to recurrent infection in adults","volume":"69","author":"Holdaway","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0355","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.molimm.2007.10.006","article-title":"Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen)","volume":"45","author":"Hummelshoj","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0360","series-title":"Genomics, Circuits, and Pathways in Clinical Neuropsychiatry","first-page":"179","article-title":"Somatic mosaicism and neurological diseases","author":"Jamuar","year":"2016"},{"key":"10.1016\/j.molimm.2019.08.002_bib0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/79.1.65","article-title":"A study of optimal reaction conditions for an assay of the human alternative complement pathway","volume":"79","author":"Joiner","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.md.0000152371.22747.1e","article-title":"Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease","volume":"84","author":"Jonsson","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molimm.2019.08.002_bib0375","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2019.08.002_bib0380","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1212\/NXG.0000000000000280","article-title":"Molecular pathogenesis of human CD59 deficiency","volume":"4","author":"Karbian","year":"2018","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.seminhematol.2018.04.004","article-title":"Congenital defects in the expression of the glycosylphosphatidylinositol-anchored complement regulatory proteins CD59 and decay-accelerating factor","volume":"55","author":"Kinoshita","year":"2018","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0390","first-page":"982","article-title":"Modern complement analysis","volume":"10","author":"Kirschfink","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0395","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2002.tb00316.x","article-title":"Lupus erythematosus associated with C1 inhibitor deficiency","volume":"29","author":"Koide","year":"2002","journal-title":"J. Dermatol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00001","article-title":"Keeping it all going-complement meets metabolism","volume":"8","author":"Kolev","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2019.08.002_bib0410","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1992.365","article-title":"Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas","volume":"66","author":"Koretz","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molimm.2019.08.002_bib0415","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMc1707173","article-title":"Loss of CD55 in eculizumab-responsive protein-losing enteropathy","volume":"377","author":"Kurolap","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000492944","article-title":"Catch me if you can: streptococcus pyogenes complement evasion strategies","volume":"11","author":"Laabei","year":"2019","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.molimm.2019.08.002_bib0425","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","article-title":"Complement evasion by human pathogens","volume":"6","author":"Lambris","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2017.07.011","article-title":"Post-eculizumab meningococcaemia in vaccinated patients","volume":"24","author":"Lebel","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.molimm.2019.08.002_bib0435","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0440","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/rth2.12175","article-title":"Hereditary angioedema: linking complement regulation to the coagulation system","volume":"3","author":"Levi","year":"2019","journal-title":"Res Pract Thromb Hemost"},{"key":"10.1016\/j.molimm.2019.08.002_bib0445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"Lewis","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.molimm.2019.08.002_bib0450","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08916930600739233","article-title":"Complement deficiencies in humans and animals: links to autoimmunity","volume":"39","author":"Lewis","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2019.08.002_bib0455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2019.08.002_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199305","article-title":"Clinical features of patients with homozygous complement C4A or C4B deficiency","volume":"13","author":"Liesmaa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0465","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/0961203310373370","article-title":"Cutaneous manifestations of complement deficiencies","volume":"19","author":"Lipsker","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.molimm.2019.08.002_bib0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pathol-012615-044145","article-title":"Complement dysregulation and disease: insights from contemporary genetics","volume":"12","author":"Liszewski","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0475","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","article-title":"Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor","volume":"376","author":"Longhurst","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060237","article-title":"Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease","volume":"8","author":"Luz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0485","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0490","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","article-title":"A hybrid CFHR3-1 gene causes familial C3 glomerulopathy","volume":"23","author":"Malik","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0495","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.08.002_bib0500","first-page":"142","article-title":"Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function","author":"Martinon-Torres","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.molimm.2019.08.002_bib0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-1759(89)90025-2","article-title":"Assay of complement activity in human serum using large unilamellar liposomes","volume":"123","author":"Masaki","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.08.002_bib0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smim.2013.04.002","article-title":"Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis","volume":"25","author":"Mastellos","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0515","series-title":"Experimental Immunochemistry","article-title":"Complement and complement fixation, p. 133\u2013240","author":"Mayer","year":"1961"},{"key":"10.1016\/j.molimm.2019.08.002_bib0520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2015.02.032","article-title":"Age-related macular degeneration and the role of the complement system","volume":"67","author":"McHarg","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0525","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","article-title":"Ravulizumab: first global approval","volume":"79","author":"McKeage","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.molimm.2019.08.002_bib0530","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0535","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0540","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0961203309357059","article-title":"C1-inhibitor autoantibodies in SLE","volume":"19","author":"Meszaros","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.molimm.2019.08.002_bib0545","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ana.24770","article-title":"Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation","volume":"80","author":"Mevorach","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0550","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.imbio.2015.01.003","article-title":"Primary Ficolin-3 deficiency--Is it associated with increased susceptibility to infections?","volume":"220","author":"Michalski","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2019.08.002_bib0555","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fimmu.2018.00612","article-title":"Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases","volume":"9","author":"Michels","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0560","first-page":"42","article-title":"Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies","volume":"1766","author":"Mikesch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2019.08.002_bib0565","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000467856","article-title":"Early- and late-phase activation of complement evaluated by plasma levels of C3d,g and the terminal complement complex","volume":"2","author":"Mollnes","year":"1985","journal-title":"Complement"},{"key":"10.1016\/j.molimm.2019.08.002_bib0570","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2249.1993.tb05898.x","article-title":"Complement activation in septic baboons detected by neoepitope-specific assays for C3b\/iC3b\/C3c, C5a and the terminal C5b-9 complement complex (TCC)","volume":"91","author":"Mollnes","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0575","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0580","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1056\/NEJMoa0900381","article-title":"Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency","volume":"360","author":"Munthe-Fog","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006679","article-title":"COLEC10 is mutated in 3MC patients and regulates early craniofacial development","volume":"13","author":"Munye","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(84)90432-0","article-title":"Simplified assays of hemolytic activity of the classical and alternative complement pathways","volume":"72","author":"Nilsson","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.08.002_bib0595","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.semnephrol.2010.06.006","article-title":"Genetics and genetic testing in hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura","volume":"30","author":"Noris","year":"2010","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0600","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","article-title":"Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015","volume":"66","author":"Noris","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.seminhematol.2018.05.014","article-title":"C3-mediated extravascular hemolysis in PNH on eculizumab: mechanism and clinical implications","volume":"55","author":"Notaro","year":"2018","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0610","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement--their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0615","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3389\/fimmu.2018.03125","article-title":"Complement activation as a helping hand for inflammophilic pathogens and Cancer","volume":"9","author":"Okroj","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0620","first-page":"516","article-title":"Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors","volume":"82","author":"Oppermann","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2019.08.002_bib0625","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0030-1262883","article-title":"Complement in typical hemolytic uremic syndrome","volume":"36","author":"Orth","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.molimm.2019.08.002_bib0630","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0635","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0640","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJMoa1615887","article-title":"CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis","volume":"377","author":"Ozen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0645","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3389\/fimmu.2019.01007","article-title":"The challenges and promise of complement therapeutics for ocular diseases","volume":"10","author":"Park","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0650","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0655","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","article-title":"Systemic lupus erythematosus, complement deficiency, and apoptosis","volume":"76","author":"Pickering","year":"2000","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0660","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1700518","article-title":"Analysis of factor d isoforms in Malpuech-Michels-Mingarelli-Carnevale patients highlights the role of MASP-3 as a maturase in the alternative pathway of complement","author":"Pihl","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0665","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0264-410X(03)00440-7","article-title":"Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine","volume":"21","author":"Platonov","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.08.002_bib0670","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molimm.2018.06.001","article-title":"Complement analysis in the era of targeted therapeutics","volume":"102","author":"Prohaszka","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0675","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1752-8062.2011.00262.x","article-title":"Paroxysmal nocturnal hemoglobinuria from bench to bedside","volume":"4","author":"Pu","year":"2011","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.molimm.2019.08.002_bib0680","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMc1106619","article-title":"Eculizumab and refractory membranoproliferative glomerulonephritis","volume":"366","author":"Radhakrishnan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0685","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"Ram","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2019.08.002_bib0690","series-title":"Molecular Basis of Complement Action","author":"Rapp","year":"1970"},{"key":"10.1016\/j.molimm.2019.08.002_bib0695","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2017.02.002","article-title":"A novel antihuman C3d monoclonal antibody with specificity to the C3d complement split product","volume":"444","author":"Rasmussen","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.08.002_bib0700","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","article-title":"C3 glomerulopathy: ten years\u2019 experience at mayo clinic","volume":"93","author":"Ravindran","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.molimm.2019.08.002_bib0705","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2018.03.087","article-title":"A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"36","author":"Reher","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.08.002_bib0710","first-page":"155","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand","volume":"63","author":"Reis","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0715","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.05.013","article-title":"Complement in clinical medicine: clinical trials, case reports and therapy monitoring","volume":"89","author":"Ricklin","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0720","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0725","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - the \u201cSwiss Army Knife\u201d of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2019.08.002_bib0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093459","article-title":"Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels","volume":"9","author":"Ristau","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0735","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.molimm.2019.08.002_bib0740","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng.757","article-title":"Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome","volume":"43","author":"Rooryck","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0745","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005792-198409000-00001","article-title":"Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency","volume":"63","author":"Ross","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molimm.2019.08.002_bib0750","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(82)90386-6","article-title":"A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes","volume":"51","author":"Rother","year":"1982","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.08.002_bib0755","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.08.002_bib0760","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/1744666X.2015.1012502","article-title":"Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)","volume":"11","author":"Sabharwal","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0765","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/eye.2016.328","article-title":"Local complement activation in aqueous humor in patients with age-related macular degeneration","volume":"31","author":"Schick","year":"2017","journal-title":"Eye Lond. (Lond)"},{"key":"10.1016\/j.molimm.2019.08.002_bib0770","doi-asserted-by":"crossref","first-page":"e2593","DOI":"10.1371\/journal.pone.0002593","article-title":"Systemic complement activation in age-related macular degeneration","volume":"3","author":"Scholl","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0775","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","article-title":"Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2019.08.002_bib0780","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1399-3038.2001.012003166.x","article-title":"Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up","volume":"12","author":"Schwertz","year":"2001","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0785","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2019.08.002_bib0790","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/rheumatology\/keh417","article-title":"A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus","volume":"44","author":"Seelen","year":"2005","journal-title":"Rheumatology Oxford (Oxford)"},{"key":"10.1016\/j.molimm.2019.08.002_bib0795","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with hemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0800","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000348654","article-title":"C3 glomerulopathy","volume":"181","author":"Servais","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0805","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.molimm.2019.08.002_bib0810","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajhg.2010.09.018","article-title":"MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes","volume":"87","author":"Sirmaci","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0815","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molimm.2011.05.001","article-title":"Complement deficiency states and associated infections","volume":"48","author":"Skattum","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0820","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMc1306326","article-title":"Deficiency in complement factor B","volume":"369","author":"Slade","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0825","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"311\u2013314","key":"10.1016\/j.molimm.2019.08.002_bib0830","first-page":"e316","article-title":"A type III complement factor D deficiency: structural insights for inhibition of the alternative pathway","volume":"142","author":"Sng","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0835","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/imj.13160","article-title":"Changing prognosis in paroxysmal nocturnal hemoglobinuria disease subcategories: an analysis of the International PNH Registry","volume":"46","author":"Socie","year":"2016","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.molimm.2019.08.002_bib0840","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2015.03.007","article-title":"Clinical presentation of human C1q deficiency: How much of a lupus?","volume":"67","author":"Stegert","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0845","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJMoa022836","article-title":"Inherited deficiency of mannan-binding lectin-associated serine protease 2","volume":"349","author":"Stengaard-Pedersen","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.08.002_bib0850","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molimm.2019.08.002_bib0855","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ajt.12032","article-title":"Meningococcal sepsis complicating eculizumab treatment despite prior vaccination","volume":"13","author":"Struijk","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.molimm.2019.08.002_bib0860","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2017.05.024","article-title":"Demyelination, strokes, and eculizumab: lessons from the congenital CD59 gene mutations","volume":"89","author":"Tabib","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0865","first-page":"63","article-title":"Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation","volume":"12","author":"Teisner","year":"1983","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0870","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020908","article-title":"Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. Tuberculosis","volume":"6","author":"Thye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0880","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajmg.a.30878","article-title":"Michels syndrome, Carnevale syndrome, OSA syndrome, and Malpuech syndrome: variable expression of a single disorder (3MC syndrome)?","volume":"137A","author":"Titomanlio","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.molimm.2019.08.002_bib0885","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fimmu.2018.00581","article-title":"The C3dg fragment of complement is superior to conventional C3 as a diagnostic biomarker in systemic lupus erythematosus","volume":"9","author":"Troldborg","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0890","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2015.05.007","article-title":"Classical pathway deficiencies - A short analytical review","volume":"68","author":"Truedsson","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0895","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2019.08.002_bib0900","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.humimm.2011.06.016","article-title":"MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection","volume":"72","author":"Tulio","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0905","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10875-015-0137-5","article-title":"Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe","volume":"35","author":"Turley","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2019.08.002_bib0915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.12.017","article-title":"Complement in autoimmune diseases","volume":"465","author":"Vignesh","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.molimm.2019.08.002_bib0920","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/eye.2017.245","article-title":"Genetics and genetic testing for age-related macular degeneration","volume":"32","author":"Warwick","year":"2018","journal-title":"Eye Lond. (Lond)"},{"key":"10.1016\/j.molimm.2019.08.002_bib0925","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0930","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0031-1273095","article-title":"Thrombosis in patients with paroxysmal nocturnal hemoglobinuria","volume":"37","author":"Weitz","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.molimm.2019.08.002_bib0935","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-immunol-042617-053245","article-title":"Complement and the regulation of t cell responses","volume":"36","author":"West","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0940","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of complement dysregulation-an overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0945","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.molimm.2019.08.002_bib0950","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000075689","article-title":"The intricate role of complement component C4 in human systemic lupus erythematosus","volume":"7","author":"Yang","year":"2004","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.molimm.2019.08.002_bib0955","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation","volume":"25","author":"Zand","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0960","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00439-013-1273-8","article-title":"Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China","volume":"132","author":"Zhang","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molimm.2019.08.002_bib0965","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview","volume":"5","author":"Ziakas","year":"2007","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.molimm.2019.08.002_bib0970","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0090-1229(80)90058-6","article-title":"Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema","volume":"15","author":"Ziccardi","year":"1980","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0975","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.08.002_bib0980","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaci.2018.01.015","article-title":"Hereditary angioedema with normal C1 inhibitor: four types and counting","volume":"141","author":"Zuraw","year":"2018","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019305036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019305036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:35:52Z","timestamp":1758980152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019305036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":196,"alternative-id":["S0161589019305036"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.08.002","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}